Our partner IMéBIO, a company expert in modular technical environments for biotechnology and health, has delivered a mobile and autonomous BSL-3 laboratory of 45 m2 to allow us to amplify our collaborative research activities in the fight against emerging and re-emerging infectious diseases. These additional laboratory spaces will in particular make it possible to accelerate our various R&D programs carried out with our spin-off VirexpR in the field of microbiological contamination of indoor air, and with several other industrial partners of the Région Auvergne-Rhône-Alpes. This top-quality mobile BSL-3 laboratory with high containment (ISO regulation 14644-1/4) is compliant with the main international standards and guidelines (WHO, CDC…). We are very proud of this synergy of multidisciplinary expertise and complementary technologies, which allows us collectively to respond in a more reactive and agile way to major public health issues. These public-private partnerships are a major asset for Virnext commitment to contributing to the national and European sovereignty of the means of protection against emerging and re-emerging infectious diseases, as well as to the development in the Auvergne-Rhône-Alpes region of French industries and their international competitiveness.